Opamtistomig
Opamtistomig is a humanized immunoglobulin (H-γ1-scFv-L-κ) dimer monoclonal antibody targeting human programmed death ligand 1 (PD-L1), CD274 and tumor necrosis factor receptor superfamily member 9 (TNFRSF9) . Opamtistomig is promising for research of various solid tumors and hematological malignancies[1].
Product Specifications
CAS Number
[2923499-76-5]
UNSPSC
12352203
Target
PD-1/PD-L1; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
134692 100 µg
TRAPPC2 (Trafficking Protein Particle Complex Subunit 2, Sedlin, SEDL)
Ask
View Details 
